Skip to content

FREnch Survey on Heart Failure

FREnch Survey on Heart Failure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01956539
Acronym
FRESH
Enrollment
2719
Registered
2013-10-08
Start date
2014-02-28
Completion date
2022-05-31
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Observational Study

Brief summary

Heart failure is the most common heart disease with increasing incidence due to the aging of the population is improving the initial prognosis of various conditions that lead to more or less progressive heart failure. Heart failure is of great variety of clinical and pathophysiological forms necessitating the creation of quality records to clarify each of these forms. Many types of cardiomyopathies exist, some of which are infrequent but with specific care. At the French level, few data exist. In addition, the therapeutic management changes regularly. New European recommendations (endorsed by the French Society of Cardiology = FSC) were published in May 2012. Many therapeutic approaches are being evaluated. The course of care and how to take non-drug load (network monitoring, rehabilitation ...) have become important issues that have hardly been analyzed by existing records. This also leads to better define the different forms of this disease, their natural history and methods of management applied in real life. The register of FSC follows the registry of the European Society of Cardiology (ESC)Heart Failure (HF) Long Term (CCTIRS No. 11.355bis) with inclusions will be completed in November 2012. This new study aims to generate more accurate data on a number of points and be more representative for a wider selection of patients, the French level.

Detailed description

The recruitment period will be 24 months, with a day of inclusion for each week, which will be included both patients external consultant for chronic heart failure patients hospitalized in the cardiology department, during this day for acute heart failure. Monitoring will be carried out 12 months during a consultation normally scheduled for this type of pathology with the cardiologist investigator. Patients included in a decompensation will also follow up to 3 months

Interventions

None listed

Sponsors

French Cardiology Society
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient with chronic HF OR patient hospitalized foor acute HF de novo or not * patient who accept to participate by signing a informed consent

Exclusion criteria

* patient who deny to participate

Design outcomes

Primary

MeasureTime frameDescription
Mortality at one-year of follow-up12 monthsDeath rate at 12 months of follow-up

Secondary

MeasureTime frameDescription
Morbidity at one year of follow-up12 monthsCollect Chronic obstructive pulmonary disease (COPD) and diabetes mellitus during one year of follow-up, which frequently are associated with heart failure and impact patient outcomes

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026